Effect of Agonist Contract Relax Versus Antagonist Contract Relax in Chronic Stroke Patient.
NCT ID: NCT05957731
Last Updated: 2023-08-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
112 participants
INTERVENTIONAL
2022-11-07
2023-07-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Outcome measures are range of motion and spasticity. The protocol was implemented three days per week for eight consecutive weeks. Data will be collected at baseline and 8 th week after intervention.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Active Release Versus Strain-Counter-strain Technique in Patients With Non-Specific Neck Pain
NCT07026006
Effects of Upper Trapezius Stretching With and Without Mid Lower Trapezius Strengthening in Trapezius Myalgia
NCT05856006
Manual Therapy vs Stretching vs Routine Physical Therapy in Nonspecific Chronic Neck Pain
NCT04913441
Effects of Comprehensive Correcting Exercise Program and Mckenzie Exercises in Patients With Sternosymphyseal Syndrome
NCT06751771
Effects of Autogenic and Reciprocal Inhibition, Muscle Energy Techniques in the Management of Mechanical Neck Pain
NCT03136250
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Null hypothesis (H0):
There are no comparative effects of agonist contact-relax technique and the antagonist contract-relax technique on spasticity and ankle range of motion in chronic patients.
The alternate hypothesis (HA):
There are comparative effects of agonist contract-relax technique and the antagonist contract-relax technique on spasticity and ankle range of motion in chronic stroke patients.
The sample size came out to 94 (47 in each group) after adding 20% dropout the sample size was 47+9=56 in each group.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Agonist Contract-relax group:
In the agonist contract-relax group, participants were positioned in a supine position. A trained physiotherapist then passively dorsiflexed the ankle to its maximum available range and held it for 15 seconds, while ensuring that the knee remained straight by placing a hand on it. Following this, participants were instructed to perform a maximal voluntary isometric
35
contraction of the planter flexors for five seconds, while maintaining the stretched position.
After a 30-second rest period, the physiotherapist returned the ankle to the starting position of 0 degrees and repeat the procedure without any rest. This stretching protocol was repeated four times, with each repetition lasting 2 minutes. For the soleus muscles, the same procedure was performed, but with a slightly flexed initial position of the knee.
Routine physical therapy
Both groups received routine physical therapy, which encompasses various components such as electrotherapy, strength training for both lower and upper limbs, gait training, and occupational therapy.
agonist contract relax
agonist contraction is used to improve spasticity and range of motion in stroke patients
Antagonist contract-relax group:
In the antagonist stretching groups, participants were positioned in a supine position. A trained physiotherapist stretched the antagonist\'s muscle, and then participants were instructed to perform a maximal voluntary isometric contraction of dorsiflexion for 5 seconds while maintaining a stretched position. The knee was kept straight during this contraction.
Following the contraction, the physiotherapist held the ankle at that angle for another 10 seconds by placing a hand on it. After a 30-second rest period, the physiotherapist returned the ankle to the starting position of 0 degrees and repeat the procedure without any rest intervals.
Routine physical therapy
Both groups received routine physical therapy, which encompasses various components such as electrotherapy, strength training for both lower and upper limbs, gait training, and occupational therapy.
antagonist contract relax
antagonist contraction i used to improve spasticity and range of motion in stroke patients
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Routine physical therapy
Both groups received routine physical therapy, which encompasses various components such as electrotherapy, strength training for both lower and upper limbs, gait training, and occupational therapy.
antagonist contract relax
antagonist contraction i used to improve spasticity and range of motion in stroke patients
agonist contract relax
agonist contraction is used to improve spasticity and range of motion in stroke patients
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Inclusion of patients with both ischemic and hemorrhagic stroke.
* Both male and female patients are eligible.
* Age range between 40 to 60 years.
* Modified Ashworth Scale ranging from 0 to 2.
* Minimum muscle strength grade of 3
Exclusion Criteria
* Who received injection therapies for reducing spasticity
* Lower extremity contracture
* Modified Ashworth scale of 3-4
40 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Lahore
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
sir Ganga Raam hospital lahore
Lahore, , Pakistan
univerity of Lahore teaching hopital
Lahore, , Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
REC-UOL-246-04-2023
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.